Drawing for HEALIOSTEM

USPTO serial 88792445

HEALIOSTEM

Reviewed by CopyMark Law Group

Reg. 6505005Status 700Renewal
Filing date
Status date
Registration date
Oct 5, 2021
Examiner
KUNG, KAELIE ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEALIOSTEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey J. Watson

Stacey J. Watson MARKERY LAW LLCP.O. BOX 84150GAITHERSBURG, MD 20883UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001stem cells, other than for medical or veterinary purposes; stem cells for research purposes; stem cells for scientific purposesACTIVE—
005adjuvants for medical purposes; cells for medical use; biological cell preparations for the treatment of diseases and disorders, namely, ophthalmic, central nervous, respiratory, cardiovascular, liver, kidney, pancreatic, type 1 and type 2 diabetes, oncological, urological, peripheral artery, gynecological disease, and stroke; pharmaceutical preparations for the prevention or treatment of ophthalmic, central nervous, respiratory, cardiovascular, liver, kidney, pancreatic, type 1 and type 2 diabetes, oncological, urological, peripheral artery, gynecological disease, and stroke; stem cells for veterinary purposesACTIVE—
010medical apparatus and instruments for use in surgery, apparatus for the regeneration of stem cells for medical purposes, surgical instruments and apparatus, surgical and medical apparatus and instruments for use in general surgery, medical instruments for cutting tissue, needles for medical purposes, medicinal catheters, medical instruments for interstitial thermotherapy of biological tissue, prosthetic tissues for parietal, visceral and vascular use, artificial bones for implantation, syringes for medical purposes for injections, and eye testing machines and apparatus; medical apparatus and instruments for treating of ophthalmic, central nervous, respiratory, cardiovascular, liver, kidney, pancreatic, type 1 and type 2 diabetes, oncological, urological, gynecological disease, and strokeACTIVE—
040custom processing of human cells; processing of biological cells for medical treatmentACTIVE—
042scientific and medical research and development in the field of cells; research and development of pharmaceuticals and medical apparatus and instruments for others; research and development services relating to medicines; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffsACTIVE—
044medical informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 5, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2021FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jun 11, 2021ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2021ALIEASSIGNED TO LIE—
Feb 26, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 22, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 22, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 22, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 2, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 2, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Dec 2, 2020CNSLSUSPENSION LETTER WRITTEN—
Dec 2, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Dec 2, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 2, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 2, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 5, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 5, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Nov 5, 2020CNSLSUSPENSION LETTER WRITTEN—
Oct 30, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2020DOCKASSIGNED TO EXAMINER—
Feb 19, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 19, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 19, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 19, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 15, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance